Advanced Medical Solutions Group PLC

NEW
CHIX:AMSl (UK)  
£ 2.7925 +0.013 (+0.45%) Jun 26
62.33
P/B:
2.35
Market Cap:
£ 609.39M ($ 817.66M)
Enterprise V:
£ 674.21M ($ 904.63M)
Volume:
485.06K
Avg Vol (2M):
192.25K
Trade In:
Volume:
485.06K
Avg Vol (2M):
192.25K

Business Description

Description
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.

Advanced Medical Solutions Group PLC Filings

Filing Date Document Date Form
No Filing Data

Advanced Medical Solutions Group PLC Stock Events

Financials Calendars
Event Date Price (£)
Second quarter earnings conference call for 2026 2026-09-17 13:30 In 83 days
Second quarter earnings results for 2026 2026-09-17 In 82 days
General meeting for 2025 2026-06-17 10:00 2.15 (+0.47%)
GBP 0.020100 Cash Dividend 2026-05-28 2.19 (+1.04%)
Annual report for 2025 2026-05-15 2.54 (+2.01%)
Fourth quarter earnings results for 2025 2026-03-18 1.99 (+3.65%)
GBP 0.008500 Cash Dividend 2025-09-25 2.22 (+3.02%)
Second quarter earnings conference call for 2025 2025-09-17 13:30 2.07 (+0.24%)
Second quarter earnings results for 2025 2025-09-17 2.07 (+0.24%)
General meeting for 2024 2025-06-30 11:00 2.15 (-0.58%)
Show
Entries

Press Release

Subject Date
No Press Release

Articles on Advanced Medical Solutions Group PLC

No articles.